Particle.news
mRNA Technology Clinical Trials mRNA Vaccines Infectious Diseases Immunology Clinical Research COVID-19 Vaccines Public Health Research mRNA Research Viral Vaccines Infectious Disease Research COBRA Method Universal Vaccines COVID-19 Vaccine Companies COVID-19 Indigenous Vaccines Cervical Cancer Covid-19 Vaccines AI Applications RSV Vaccines Adjuvant Research Avian Flu Vaccines DNA-based Vaccines Virus-Like Particle Technology Nanoparticle Technology Innovative Technologies Antivenoms Mycobacterium tuberculosis Cancer Immunotherapy African Swine Fever Vaccine Animal Vaccines Respiratory Syncytial Virus Innovations in Vaccines
Unanimous advisory support advances the shot toward licensure; final FDA action is due by Aug. 5, with CDC coverage unsettled by ACIP’s inability to convene.
